These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7865229)

  • 1. Is coronary artery disease associated with radiotherapy preventable by salicylates?
    Michalowski AS
    Acta Oncol; 1995; 34(1):126. PubMed ID: 7865229
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylsalicylic acid is unlikely to beneficially interfere with radiation-induced vasculopathy.
    Sinzinger H; Karanikas G; Kritz H
    Acta Oncol; 1997; 36(3):341. PubMed ID: 9208908
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug modulation of thromboxane A2/prostacyclin balance and lipid peroxidation in patients with coronary artery disease].
    Zhao X; Zhang YH; Feng HF
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):476-8, 510-1. PubMed ID: 2086017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological correction of disorders of the prostacyclin- thromboxane balance in ischemic heart disease: problems and prospects].
    Markov KhM
    Kardiologiia; 1990 Apr; 30(4):111-8. PubMed ID: 2118578
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostaglandins and ischemic cardiopathy].
    Strano A; Davì G
    Cardiologia; 1985 Apr; 30(4):261-4. PubMed ID: 3914359
    [No Abstract]   [Full Text] [Related]  

  • 6. [The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
    Bakhoviddinova GSh
    Vrach Delo; 1991 Sep; (9):36-8. PubMed ID: 1759428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 8. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 9. MI: recent insights--and new treatments?
    Zoler ML
    Geriatrics; 1984 May; 39(5):123, 128, 133 passim. PubMed ID: 6370792
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):294-304. PubMed ID: 6363769
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without hereditary predisposition to ischemic heart disease].
    Akimov EV
    Kardiologiia; 1992 May; 32(5):41-3. PubMed ID: 1405259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic components of acute ischemic syndromes. Focus on acute ischemic stimuli.
    Maseri A
    Circulation; 1990 Jan; 81(1 Suppl):I1-3; discussion I22-3. PubMed ID: 2295147
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ischemic heart disease and prostanoids: pathogenesis and its implications for treatment].
    Aoyama T; Yui Y; Hattori R; Kawai C
    Nihon Rinsho; 1990 Jun; 48(6):1229-33. PubMed ID: 2117082
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans.
    Nowak J; FitzGerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():208-11. PubMed ID: 2959050
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of drugs on the TXA2/PGI2 balance and on the atherogenic index in myocardial ischemia in dogs.
    Beitz A; Taube C; Beitz J; Goos H; Graff J; Nohring J; Lindenau KF; Mest HJ
    Biomed Biochim Acta; 1988; 47(10-11):S149-52. PubMed ID: 2470353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies.
    Schiff E; Peleg E; Goldenberg M; Rosenthal T; Ruppin E; Tamarkin M; Barkai G; Ben-Baruch G; Yahal I; Blankstein J
    N Engl J Med; 1989 Aug; 321(6):351-6. PubMed ID: 2664522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and coronary heart disease: therapy update.
    Mehta JL
    Geriatrics; 1982 May; 37(5):129-34, 139. PubMed ID: 7040169
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of prostacyclin and thromboxane A2 in ischaemic heart disease.
    Neri Serneri GG; Gensini GF; Masotti G; Abbate R; Morettini A; Poggesi L; Fortini A
    Adv Exp Med Biol; 1984; 164():175-85. PubMed ID: 6364706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.